Related Experiment Video

Updated: Jul 7, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

High-dose chemotherapy for recurrent medulloblastoma: time for a reappraisal

Amar Gajjar

    Cancer
    |February 29, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
    05:10

    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

    Published on: October 3, 2010

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    Related Experiment Videos

    Last Updated: Jul 7, 2026

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
    05:10

    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

    Published on: October 3, 2010

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Conventionally Fractionated Re-irradiation for Recurrent Ependymoma.

    Neuro-oncology·2026

    Longitudinal Changes in Pulmonary Function After Treatment of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study.

    Annals of the American Thoracic Society·2026

    Paediatric therapeutic development workshop on medulloblastoma.

    British journal of cancer·2026

    Surgical resection in medulloblastoma: a crossroads in the molecular era.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2026

    Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

    EClinicalMedicine·2026

    Neoadjuvant chemotherapy for pineal region tumors.

    Journal of neuro-oncology·2026

    Elevated risk of ischemic stroke after invasive cancer diagnosis: A nationwide population-based study.

    Cancer·2026

    Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

    Cancer·2026

    GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

    Cancer·2026

    Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

    Cancer·2026

    The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.

    Cancer·2026

    Racial differences in multiple myeloma survival: Associations with stem cell transplantation, insurance, and Medicaid expansion.

    Cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us